genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with...

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

1/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

2/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

3/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

4/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

5/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

6/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

7/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

8/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

9/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

10/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

11/12

7/31/2019 Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung

12/12